Houda Alachkar
Houda Alachkar
Verified email at usc.edu
Cited by
Cited by
TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis
Y Matsuo, JH Park, T Miyamoto, S Yamamoto, S Hisada, H Alachkar, ...
Science translational medicine 6 (259), 259ra145-259ra145, 2014
WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck
V Saloura, HS Cho, K Kiyotani, H Alachkar, Z Zuo, M Nakakido, ...
Molecular Cancer Research 13 (2), 293-304, 2015
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients
PY Yew, H Alachkar, R Yamaguchi, K Kiyotani, H Fang, KL Yap, HT Liu, ...
Bone marrow transplantation 50 (9), 1227-1234, 2015
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia
CJ Hickey, S Schwind, HS Radomska, AM Dorrance, R Santhanam, ...
Blood, The Journal of the American Society of Hematology 121 (1), 159-169, 2013
Nicotinic α 5 receptor subunit mRNA expression is associated with distant 5′ upstream polymorphisms
RM Smith, H Alachkar, AC Papp, D Wang, DC Mash, JC Wang, LJ Bierut, ...
European Journal of Human Genetics 19 (1), 76-83, 2011
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia
J Khalife, HS Radomska, R Santhanam, X Huang, P Neviani, J Saultz, ...
Leukemia 29 (10), 1981-1992, 2015
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
H Alachkar, MBG Mutonga, KH Metzeler, N Fulton, G Malnassy, T Herold, ...
Oncotarget 5 (23), 12371, 2014
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia
H Alachkar, R Santhanam, JG Harb, DM Lucas, JJ Oaks, CJ Hickey, ...
Journal of hematology & oncology 6 (1), 1-12, 2013
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome
H Alachkar, R Santhanam, K Maharry, KH Metzeler, X Huang, ...
The Journal of clinical investigation 124 (4), 1512-1524, 2014
Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia
S Wu, Y Du, J Beckford, H Alachkar
Journal of translational medicine 16 (1), 1-9, 2018
Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia
H Alachkar, N Fulton, B Sanford, G Malnassy, M Mutonga, RA Larson, ...
The pharmacogenomics journal 17 (3), 274-279, 2017
T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia
H Alachkar, M Mutonga, G Malnassy, JH Park, N Fulton, A Woods, L Meng, ...
Oncotarget 6 (32), 33410, 2015
SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells
T Vougiouklakis, K Sone, V Saloura, HS Cho, T Suzuki, N Dohmae, ...
Oncotarget 6 (41), 43162, 2015
Targeting suppressor of variegation 3-9 homologue 2 (SUV39H2) in acute lymphoblastic leukemia (ALL)
M Mutonga, K Tamura, G Malnassy, N Fulton, A de Albuquerque, ...
Translational oncology 8 (5), 368-375, 2015
Deciphering the TCR repertoire to solve the COVID-19 mystery
L Gutierrez, J Beckford, H Alachkar
Trends in pharmacological sciences, 2020
Skin penetration and lag times of neat and aqueous diethyl phthalate, 1, 2-dichloroethane and naphthalene
H Frederick Frasch, AM Barbero, H Alachkar, JN McDougal
Cutaneous and ocular toxicology 26 (2), 147-160, 2007
Characterization of mutations in the mitochondrial encoded electron transport chain complexes in acute myeloid leukemia
S Wu, M Akhtari, H Alachkar
Scientific reports 8 (1), 1-9, 2018
Midostaurin reduces regulatory T cells markers in acute myeloid leukemia
L Gutierrez, M Jang, T Zhang, M Akhtari, H Alachkar
Scientific reports 8 (1), 1-8, 2018
Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection
H Alachkar, M Mutonga, T Kato, S Kalluri, Y Kakuta, M Uemura, ...
BMC nephrology 17 (1), 1-9, 2016
The era of immunogenomics/immunopharmacogenomics
M Zewde, K Kiyotani, JH Park, H Fang, KL Yap, PY Yew, H Alachkar, ...
Journal of human genetics 63 (8), 865-875, 2018
The system can't perform the operation now. Try again later.
Articles 1–20